References
Fujimoto Y., Oka A., Omoto R., Hirose M. Ultrasound scanning of the thyroid gland as a new diagnostic approach. Ultrasonics 1967, 5: 177–180.
Vitti P., Rago T., Mancusi F., et al. Thyroid hypoechogenic pattern at ultrasonography as a tool for predicting recurrence of hyperthyroidism after medical treatment in patients with Graves’ disease. Acta Endocrinol. (Copenh.) 1992, 126: 128–131.
Schiemann U., Gellner R., Riemann B., et al. Standardised grey scale ultrasonography in Graves’ disease: correlation to autoimmune activity. Eur. J. Endocrinol. 1999, 141: 332–336.
Rago T., Chiovato L, Grasso L, Pinchera A., Vitti P. Thyroid ultrasonography as a tool for detecting thyroid autoimmune diseases and predicting thyroid dysfunction in apparently healthy subjects. J. Endocrinol. Invest. 2001, 24: 763–769.
Espinasse P. L’echographie thyroidienne dans les thyroidites lymphocytaires chroniques autoimmunes. J. Radiol. 1983, 64: 537–544.
Gutenkust R., Hafermann W., Mansky T., Scriba P.C. Ultrasonography related to clinical and laboratory findings in lymphocytic thyroiditis. Acta Endocrinol. (Copenh.) 1989, 121: 129–135.
Ralls P.W., Mayekawa D.S., Lee K.P., et al. Color-flow doppler sonography in Graves’ disease: “thyroid inferno”. Am. J. Radiol. 1988, 150: 781–784.
Vitti P., Rago T., Mazzeo S., et al. Thyroid blood flow evaluation by color-flow doppler sonography distinguishes Graves’ disease from Hashimoto’s thyroiditis. J. Endocrinol. Invest. 1995, 18: 857–861.
Bogazzi F., Bartalena L, Brogioni S., et al. Color flow Doppler sonography rapidly differentiates type I and type II amio-darone-induced thyrotoxicosis. Thyroid 1997, 7: 541–545.
Rago T., Vitti P., Chiovato L, et al. Role of conventional ultrasonography and color flow-Doppler sonography in predicting malignancy in “cold” thyroid nodules. Eur. J. Endocrinol. 1998, 138: 41–46.
Tan G.H., Gharib H. Thyroid incidentalomas: management approches to non palpable nodules discovered incidentally on thyroid imaging. Ann. Intern. Med. 1997, 126: 226–231.
Ross D.S. Editorial: Nonpalpable thyroid nodules-managing an epidemic. J. Clin. Endocrinol. Metab. 2002, 87: 1938–1940.
Braga M., Graf H., Ogata A., Batista J., Hakim Neto C.A. Aggressive behavior of papillary microcarcinoma in patient with Graves’ disease initially presenting as cystic neck mass. J. Endocrinol. Invest. 2002, 25: 250–253.
Nabriski D., Ness-Abramof R., Brosh T., Konen O., Shapiro M.S, Shenkman L. Clinical relevance of non-palpable thyroid nodule as assessed by ultrasound-guided fine needle aspiration biopsy. J. Endocrinol. Invest. 2003, 26: 61–64.
Rago T., Chiovato L, Aghini-Lombardi F., Grasso L, Pinchera A., Vitti P. Non-palpable thyroid nodules in a borderline iodine-sufficient area: detection by ultrasonography and follow-up. J. Endocrinol. Invest. 2001, 24: 770–776.
Papini E., Guglielmi R., Bianchini A., et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J. Clin. Endocrinol. Metab. 2002, 87: 1941–1946.
Papini E. The dilemma of non-palpable thyroid nodules. J. Endocrinol. Invest. 2003, 26: 3–4.
Marcocci C, Vitti P., Cetani F., Catalano F., Concetti R., Pinchera A. Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism. J. Clin. Endocrinol. Metab. 1991, 72: 209–213.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vitti, P., Rago, T. Thyroid ultrasound as a predicator of thyroid disease. J Endocrinol Invest 26, 686–689 (2003). https://doi.org/10.1007/BF03347031
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347031